Vanguard Health Care Fund Admiral Shares
FundVGHAXNASDAQAbout
For over a quarter-century, this actively managed portfolio has offered investors an economical gateway to companies worldwide operating within the healthcare sector. Its holdings encompass pharmaceutical giants, medical equipment manufacturers, and cutting-edge research organizations. Compared to its peers in the healthcare space, this fund typically exhibits broader international exposure and a lower portfolio turnover rate. Nevertheless, investors should acknowledge the inherent concentration risk, as it exclusively targets the health care industry. Given that annual returns can fluctuate significantly, this fund is best suited as a supplementary component within a well-diversified investment strategy, particularly for those with a lengthy time horizon.
Key Facts
52-Week Range
Performance
Sector Exposure
- Basic Materials0.00%
- Cash & Others0.48%
- Consumer Defensive1.24%
- Financial Services0.01%
- Healthcare98.26%
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 9.16% | $3.37B |
| MRK | Merck & Co Inc | 5.83% | $2.14B |
| AZN.L | AstraZeneca PLC | 5.27% | $1.94B |
| JNJ | Johnson & Johnson | 3.46% | $1.27B |
| GSK.L | GSK PLC | 3.40% | $1.25B |
| EW | Edwards Lifesciences Corp | 3.23% | $1.19B |
| UNH | UnitedHealth Group Inc | 2.91% | $1.07B |
| ISRG | Intuitive Surgical Inc | 2.54% | $933.61M |
| DHR | Danaher Corp | 2.50% | $917.00M |
| BSX | Boston Scientific Corp | 2.47% | $907.44M |
| ABT | Abbott Laboratories | 2.31% | $848.06M |
| UCB.BR | UCB SA | 2.27% | $835.55M |
| ARGX.BR | Argenx SE | 2.26% | $831.76M |
| COR | Cencora Inc | 2.02% | $742.58M |
| VRTX | Vertex Pharmaceuticals Inc | 1.98% | $727.23M |
| CVS | CVS Health Corp | 1.91% | $700.72M |
| NOVN.SW | Novartis AG | 1.69% | $620.60M |
| ELV | Elevance Health Inc | 1.50% | $550.20M |
| ALNY | Alnylam Pharmaceuticals Inc | 1.45% | $533.29M |
| HCA | HCA Healthcare Inc | 1.45% | $532.23M |
| REGN | Regeneron Pharmaceuticals Inc | 1.42% | $521.23M |
| CAH | Cardinal Health Inc | 1.38% | $508.19M |
| UTHR | United Therapeutics Corp | 1.38% | $507.44M |
| 4578.T | Otsuka Holdings Co Ltd | 1.30% | $478.39M |
| 4519.T | Chugai Pharmaceutical Co Ltd | 1.29% | $474.62M |